MetLife Investment Management’s Orchid Island Capital ORC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$712K Buy
101,302
+16,372
+19% +$124K ﹤0.01% 1575
2025
Q4
$611K Buy
84,930
+9,828
+13% +$71.6K ﹤0.01% 1701
2025
Q3
$526K Buy
75,102
+10,302
+16% +$73.3K ﹤0.01% 1782
2025
Q2
$454K Buy
64,800
+23,163
+56% +$161K ﹤0.01% 1721
2025
Q1
$313K Sell
41,637
-5,622
-12% -$46.2K ﹤0.01% 1951
2024
Q4
$368K Buy
47,259
+6,408
+16% +$50.4K ﹤0.01% 1965
2024
Q3
$336K Buy
40,851
+10,032
+33% +$82.7K ﹤0.01% 1992
2024
Q2
$257K Buy
30,819
+5,190
+20% +$44.1K ﹤0.01% 2091
2024
Q1
$229K Sell
25,629
-836
-3% -$7.11K ﹤0.01% 2122
2023
Q4
$223K Buy
26,465
+2,781
+12% +$20.7K ﹤0.01% 2182
2023
Q3
$202K Buy
23,684
+2,755
+13% +$27K ﹤0.01% 2204
2023
Q2
$217K Buy
20,929
+2,221
+12% +$23K ﹤0.01% 2224
2023
Q1
$201K Hold
18,708
﹤0.01% 2221
2022
Q4
$196K Sell
18,708
-1
-0% -$10 ﹤0.01% 2252
2022
Q3
$153K Sell
18,709
-1
-0% -$14 ﹤0.01% 2451
2022
Q2
$267K Buy
18,710
+4,076
+28% +$60.5K ﹤0.01% 2106
2022
Q1
$238K Buy
14,634
+9,385
+179% +$177K ﹤0.01% 2252
2021
Q4
$118K Sell
5,249
-3,484
-40% -$83.5K ﹤0.01% 2346
2021
Q3
$214K Buy
8,733
+5,823
+200% +$147K ﹤0.01% 2058
2021
Q2
$75.5K Sell
2,910
-4,399
-60% -$122K ﹤0.01% 2413
2021
Q1
$220K Buy
7,309
+4,922
+206% +$138K ﹤0.01% 2003
2020
Q4
$62.3K Sell
2,387
-765
-24% -$20.3K ﹤0.01% 2248
2020
Q3
$79K Sell
3,152
-3,397
-52% -$84.7K ﹤0.01% 2250
2020
Q2
$154K Hold
6,549
﹤0.01% 2048
2020
Q1
$96.6K Buy
6,549
+3,827
+141% +$104K ﹤0.01% 2096
2019
Q4
$79.6K Sell
2,722
-3,352
-55% -$96.1K ﹤0.01% 2274
2019
Q3
$175K Buy
6,074
+1,784
+42% +$54.1K ﹤0.01% 2017
2019
Q2
$136K Hold
4,290
﹤0.01% 2234
2019
Q1
$141K Hold
4,290
﹤0.01% 2171
2018
Q4
$137K Hold
4,290
﹤0.01% 2127
2018
Q3
$156K Hold
4,290
﹤0.01% 2227
2018
Q2
$161K Hold
4,290
﹤0.01% 2021
2018
Q1
$158K Hold
4,290
﹤0.01% 2014
2017
Q4
$199K Buy
+4,290
New +$211K ﹤0.01% 1927

Other funds holding ORC

MetLife Investment Management's ORC Position: Q1 2026 in Review

MetLife Investment Management increased its Orchid Island Capital (ORC) stake by 19% in Q1 2026, buying an estimated $124K and bringing the position to 101,302 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

MetLife Investment Management first reported a position in ORC in Q4 2017 and has held it in 34 quarters since. 195 funds tracked by Wall St. Rank hold ORC as of Q1 2026.

  • MetLife Investment Management held 101,302 shares of Orchid Island Capital worth $712K as of Q1 2026.
  • MetLife Investment Management bought 16,372 Orchid Island Capital shares in Q1 2026, an estimated $124K.
  • Orchid Island Capital made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1575 holding.
  • MetLife Investment Management first reported a position in Orchid Island Capital in Q4 2017 and has held it in 34 quarters since.
  • 195 funds tracked by Wall St. Rank held Orchid Island Capital as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.